+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Veeva Systems Inc (VEEV) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 53 Pages
  • June 2026
  • GlobalData
  • Veeva Systems
  • ID: 4281533
Veeva Systems Inc (VEEV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Veeva Systems Inc (Veeva) is a provider of industry cloud solutions for the global life sciences sector. The company focuses on delivering cloud software, data, and business consulting services tailored to the needs of life sciences companies. Veeva's major products include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. These solutions are designed to support pharmaceutical, biotechnology, and medical device companies in their research, development, and commercialization efforts. Veeva serves a diverse range of customers, including large global pharmaceutical companies and emerging growth firms, facilitating applications in clinical trials, regulatory compliance, and commercial operations. Veeva has business operations in the US, Japan, South Korea, Singapore, Australia, Brazil, and China. Veeva is headquartered in Pleasanton, California, the US.

Veeva Systems Inc Key Recent Developments

  • Jun 09, 2026: UCB Unifies Global Pharmacovigilance Operations With Veeva Safety
  • Jun 04, 2026: Veeva Summit Previews Falcon and Path to Agentic Biopharma
  • Jun 03, 2026: Veeva Announces Fiscal 2027 First Quarter Results
  • May 28, 2026: Veeva Quality Cloud Advances Manufacturing Operations for Kindeva

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Supernus Pharmaceuticals Inc - Key Facts
  • Supernus Pharmaceuticals Inc - Key Employees
  • Supernus Pharmaceuticals Inc - Key Employee Biographies
  • Supernus Pharmaceuticals Inc - Major Products and Services
  • Supernus Pharmaceuticals Inc - History
  • Supernus Pharmaceuticals Inc - Company Statement
  • Supernus Pharmaceuticals Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Supernus Pharmaceuticals Inc - Business Description
  • Other Break-up: Collaboration revenue (ZURZUVAE)
  • Performance
  • Other Break-up: Net Product Sales
  • Performance
  • Other Break-up: Royalty, Licensing and Other Revenues
  • Performance
  • R&D Overview
  • Supernus Pharmaceuticals Inc - Corporate Strategy
  • Supernus Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Supernus Pharmaceuticals Inc - Strengths
  • Supernus Pharmaceuticals Inc - Weaknesses
  • Supernus Pharmaceuticals Inc - Opportunities
  • Supernus Pharmaceuticals Inc - Threats
  • Supernus Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Supernus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Supernus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Supernus Pharmaceuticals Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jun 17, 2026: Supernus Expands Partnership With MERGE As Agency Of Record
  • May 06, 2026: Supernus Pharmaceuticals to Participate in Bank of America 2026 Health Care Conference
  • May 06, 2026: Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference
  • May 05, 2026: Supernus Reports First-Quarter 2026 Financial Results
  • Feb 24, 2026: Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results
  • Feb 12, 2026: Supernus Pharmaceuticals to Announce Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call on February 24, 2026
  • Nov 21, 2025: Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference
  • Nov 12, 2025: Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London
  • Oct 21, 2025: Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
  • Aug 05, 2025: Supernus Announces Second Quarter 2025 Financial Results
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Supernus Pharmaceuticals Inc, Key Facts
  • Supernus Pharmaceuticals Inc, Key Employees
  • Supernus Pharmaceuticals Inc, Key Employee Biographies
  • Supernus Pharmaceuticals Inc, Major Products and Services
  • Supernus Pharmaceuticals Inc, History
  • Supernus Pharmaceuticals Inc, Subsidiaries
  • Supernus Pharmaceuticals Inc, Key Competitors
  • Supernus Pharmaceuticals Inc, Ratios based on current share price
  • Supernus Pharmaceuticals Inc, Annual Ratios
  • Supernus Pharmaceuticals Inc, Interim Ratios
  • Supernus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Supernus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Supernus Pharmaceuticals Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Supernus Pharmaceuticals Inc, Performance Chart (2021 - 2025)
  • Supernus Pharmaceuticals Inc, Ratio Charts
  • Supernus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Supernus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026